Sweden’s success rests on an unswerving commitment to excellence in R&D and drug discovery. Per capita spending on life science is one of the highest in Europe. Swedish universities possess world class expertise in areas ranging from cancer and diabetes research to medical devices and stem cell therapies. Sweden is renowned for high quality clinical trials, biobanks and registers including the world’s largest twin register. Also, studies of how genetic and environmental factors affect health can probably be conducted more accurately than anywhere else thanks to an extensive network of national databanks.
A unique model of close collaboration between industry, academia and clinical practitioners has fostered the growth of world leading pharmaceutical companies like Astra, now a part of AstraZeneca, and Pharmacia, now a part of Pfizer.
The Swedish life science sector has great potential for investors and partners across multiple areas. Numerous projects are going on at a regional level, such as:
- The New Karolinska Solna University Hospital - strengthening Stockholm’s position as a world leading life science cluster
- The European Spallation Source (ESS) in Lund in southern Sweden – a European research facility for materials research under construction
- Gothenburg - striving for international leadership in regenerative medicine
- Umeå - a global research leader in infectious disease treatment and sports medicine
In addition to the above regional projects:
- Proven track record of success in innovation
- Access to knowledge capital through biobanks and registers, for example one of the best and largest biobanks in diabetes research worldwide
- World leader in biomaterials and orthopedic implants, transplantation, regenerative medicine, gene therapy, medical implants, drug development, genomics and proteomics, diagnostics and renal care
- World leading research in multiple therapeutic areas: oncology, neuroscience, inflammation and metabolics
- Interdisciplinary approach to biomedical research and development
- Expertise and infrastructure in the area of imaging and visualisation